2004
DOI: 10.1016/j.amjmed.2004.02.030
|View full text |Cite
|
Sign up to set email alerts
|

The antineutrophil cytoplasmic antibody–associated vasculitides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
270
2
20

Year Published

2005
2005
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 419 publications
(294 citation statements)
references
References 63 publications
2
270
2
20
Order By: Relevance
“…In our series, we have found a positivity of the ANCA (generally anti-MPO pANCA) in 26% of cases which is slightly lower than in the other series [5,19,20]. The difference between clinical manifestations of o ur study and the others series like more heart manifestation can maybe explain this low rate of ANCA positivity [22].…”
contrasting
confidence: 51%
See 1 more Smart Citation
“…In our series, we have found a positivity of the ANCA (generally anti-MPO pANCA) in 26% of cases which is slightly lower than in the other series [5,19,20]. The difference between clinical manifestations of o ur study and the others series like more heart manifestation can maybe explain this low rate of ANCA positivity [22].…”
contrasting
confidence: 51%
“…We have considered as a flare-up all new visceral attack related to Churg-Strauss vasculitis hitherto latent or asymptomatic as well as any known visceral attack requiring a rise of the corticosteroid therapy strictly of more than 50% or the addition of an immunosuppressive treatment. The FFS (Five Factor Score) evaluating the vasculitides prognostic at ANCA (Anti-cytoplasm antibodies of polynuclear neutrophils) 6 [3] has been calculated during a diagnosis and compared to the initial treatment received by the patients and to the therapeutic recommendations based on this score [4][5][6][7]. The remission rate (free from flare-up for over 6 months) to a one-year treatment has also been counted.…”
mentioning
confidence: 99%
“…Together with other conditions associated with ANCA with specificity to MPO, proteinase 3 (PR3) or other antigens, MPA constitutes a condition collectively called ANCA-associated vasculitis (AAV). 1 Although the etiology of AAV is poorly understood, substantial difference in the incidence among populations 2 and sporadic reports of multiplex families 3 suggest a role of genetic predisposition. With respect to MPO-ANCA associated vasculitis, previous studies reported association of HLA [4][5][6] and non-HLA genes, 7-10 although many of them have not been confirmed by independent studies.…”
Section: Introductionmentioning
confidence: 99%
“…The other types of systemic vasculitis that are often associated with vasculitic neuropathy are those that are commonly associated with ANCAs: Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome (15). Among these 3 disorders, peripheral nerve involvement is more common in both Churg-Strauss syndrome and microscopic polyangiitis, but devastating peripheral neuropathy can occur in Wegener's granulomatosis as well.…”
Section: Primary Systemic Vasculitidesmentioning
confidence: 99%
“…After these symptoms had been present for several weeks, the patient established care with a primary care physician. At his first appointment his erythrocyte sedimentation rate (ESR) was 42 mm/hour (normal range [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. An assay for antinuclear antibodies (ANA) was positive at a titer of 1:160 (speckled), but antibodies to double-stranded DNA and to extractable nuclear antigens (Ro, La, Sm, and RNP) were negative.…”
mentioning
confidence: 99%